Replies to post #144714 on Biotech Values

[genisi]

Actavis received a tentative approval for its version of Shire's Intuniv:

http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

[DewDiligence]

SNY’s eliglustat tartrate—a pill for Gaucher disease—hits primary endpoint in phase-3 study:

http://www.reuters.com/article/2012/10/02/us-sanofi-gaucher-idUSBRE89105U20121002

Full results will be presented in Feb 2013.